CAPSTONE INVESTMENT ADVISORS, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 294 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,349,469
-25.5%
60,298
+1.5%
0.00%
-20.0%
Q4 2023$1,810,496
+16.1%
59,380
+20.4%
0.01%
-28.6%
Q3 2023$1,559,878
+242.5%
49,332
+341.7%
0.01%
+250.0%
Q2 2023$455,43111,1680.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders